Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
85.04
+1.55 (1.86%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Kymera Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6,943 | 6,225 | 2,606 | 1,413 | 1,369 | 3,259 | |
| Market Cap Growth | 186.48% | 138.91% | 84.43% | 3.16% | -57.98% | 18.59% | |
| Enterprise Value | 5,411 | 5,330 | 1,783 | 1,059 | 791 | 2,666 | |
| Last Close Price | 83.49 | 77.81 | 40.23 | 25.46 | 24.96 | 63.49 | |
| PS Ratio | 177.21 | 158.75 | 55.35 | 17.98 | 29.25 | 44.75 | |
| PB Ratio | 4.30 | 3.94 | 3.12 | 3.58 | 2.79 | 7.09 | |
| P/TBV Ratio | 4.40 | 3.94 | 3.12 | 3.58 | 2.79 | 7.09 | |
| EV/Sales Ratio | 138.01 | 135.93 | 37.87 | 13.47 | 16.88 | 36.61 | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.11 | 0.21 | 0.04 | 0.04 | |
| Net Debt / Equity Ratio | -0.97 | -0.97 | -0.91 | -0.89 | -1.11 | -1.20 | |
| Net Debt / EBITDA Ratio | 4.54 | 4.54 | 3.04 | 2.15 | 3.40 | 5.55 | |
| Net Debt / FCF Ratio | 6.56 | 6.56 | 3.68 | 2.56 | 3.48 | 4.21 | |
| Asset Turnover | 0.03 | 0.03 | 0.06 | 0.13 | 0.08 | 0.13 | |
| Quick Ratio | 10.19 | 10.19 | 7.21 | 4.59 | 5.74 | 4.78 | |
| Current Ratio | 10.47 | 10.47 | 7.53 | 4.73 | 5.88 | 4.88 | |
| Return on Equity (ROE) | -25.78% | -25.78% | -36.38% | -33.21% | -32.60% | -26.96% | |
| Return on Assets (ROA) | -15.88% | -15.88% | -20.65% | -17.55% | -16.67% | -11.50% | |
| Return on Capital Employed (ROCE) | -20.80% | -20.80% | -28.20% | -33.80% | -30.30% | -19.60% | |
| Earnings Yield | -4.48% | -5.00% | -8.59% | -10.40% | -11.30% | -3.08% | |
| FCF Yield | -3.37% | -3.77% | -7.96% | -9.72% | -11.39% | -4.01% | |
| Buyback Yield / Dilution | -12.59% | -12.59% | -28.58% | -8.22% | -12.39% | -176.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.